Exelixis, Inc.
USD54.25
-0.03 (-0.06%)
CEO
Michael Morrissey
IPO Date
2000-04-17
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$54.63
Prev. Close
$54.28
Day Low
$54.18
Day High
$54.88
52W Low
$33.76
52W High
$55.91
Market Cap
$13.63B
Volume
0.07M
| 18.9 |
| 31 Dec 2023 | FY | 96.0% | 11.4% | 9.2% | 7.1% | 0.08 | 3.34 | 36.7 |
| 31 Dec 2022 | FY | 96.4% | 11.3% | 7.3% | 5.9% | 0.08 | 4.99 | 28.3 |
| 31 Dec 2021 | FY | 96.3% | 16.1% | 10.5% | 8.8% | 0.02 | 5.43 | 24.9 |
| 31 Dec 2020 | FY | 96.3% | 11.3% | 5.9% | 5.2% | 0.03 | 7.06 | 55.3 |
| 31 Dec 2019 | FY | 96.6% | 33.2% | 19.0% | 17.0% | 0.03 | 7.08 | 16.6 |
| 31 Dec 2018 | FY | 96.9% | 80.8% | 53.6% | 48.5% | 0.01 | 8.50 | 8.5 |
| 31 Dec 2017 | FY | 96.7% | 34.1% | 54.1% | 23.5% | 0.05 | 4.21 | 57.9 |
| 31 Dec 2016 | FY | 96.6% | -36.7% | -78.6% | -11.8% | 2.12 | 1.74 | -53.2 |
| 12.1 |
| 3 Oct 2025 | Q3 | 96.9% | 32.4% | 9.0% | 6.9% | 0.08 | 3.75 | 13.9 |
| 4 Jul 2025 | Q2 | 96.6% | 32.5% | 9.1% | 6.9% | 0.09 | 3.51 | 17.0 |
| 4 Apr 2025 | Q1 | 96.5% | 28.7% | 7.5% | 5.6% | 0.09 | 3.50 | 15.1 |
| 31 Dec 2024 | Q4 | 96.5% | 24.7% | 6.2% | 4.7% | 0.09 | 3.63 | 16.9 |
| 27 Sept 2024 | Q3 | 96.8% | 21.9% | 5.2% | 4.0% | 0.09 | 3.93 | 15.7 |
| 28 Jun 2024 | Q2 | 97.2% | 35.5% | 10.7% | 8.2% | 0.09 | 4.27 | 7.2 |
| 29 Mar 2024 | Q1 | 95.0% | 8.8% | 1.8% | 1.3% | 0.09 | 3.46 | 47.8 |
| 31 Dec 2023 | Q4 | 95.5% | 17.8% | 3.8% | 2.9% | 0.08 | 3.34 | 21.6 |